joint pain tirzepatide POS0209 IMPACT OF ON MUSCULOSKELETAL AND RISKY ANALGESIC USE AMONG NON-DIABETIC INDIVIDUALS WITH OVERWEIGHT OR OBESE BODY HABITUS: A PROPENSITY SCORE-MATCHED, ACTIVE COMPARATOR, NEW USER DESIGN STUDY Category: Shakes Mg size:40mg Muscle loss is one

joint pain tirzepatide POS0209 IMPACT OF ON MUSCULOSKELETAL AND RISKY ANALGESIC USE AMONG NON-DIABETIC INDIVIDUALS WITH OVERWEIGHT OR OBESE BODY HABITUS: A PROPENSITY SCORE-MATCHED, ACTIVE COMPARATOR, NEW USER DESIGN STUDY Category: Shakes Mg size:40mg Muscle loss is one

Muscle loss is one of the most common concerns raised about GLP-1 medications, and it deserves a more precise answer than it usually gets. A recently published mouse study added ketone supplementation

mazdutide 9 mg at 48 weeks is ~18%

Category: Shakes

Mg size:40mg

Real-world data from retrospective studies have echoed these findings, though with slightly lower numbers for both medications